Full Press Release Details
Allogene Therapeutics to Showcase Clinical Data from the ALPHA, ALPHA2 and UNIVERSAL AlloCAR T Trials at the 63rd Annual Meeting of the American Society of Hematology.
ALLO
Allogene Therapeutics to Showcase Clinical Data from the ALPHA, ALPHA2 and UNIVERSAL AlloCAR T Trials at the 63rd Annual Meeting of the American Society of Hematology
Key Takeaway: Allogene Therapeutics to Showcase Clinical Data from the ALPHA, ALPHA2 and UNIVERSAL AlloCAR T Trials at the 63rd Annual Meeting of the American Society of Hematology